As Annual Recurring Revenue Accelerates, CrowdStrike Buy?
CrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
Recognizing warning signs of poor investments can help you avoid costly mistakes. Stay proactive in your financial decisions.
13,809 articlesCrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
Goldman Sachs and JPMorgan cut targets on Kohl’s as consumer demand cools, signaling a tougher 2026. The moves come a...
A major fund exits a Buckle stake, triggering questions about strategy and market signals. This article breaks down w...
Two discount retailers face off for 2026 returns, with Dollar Tree highlighting a store-format push and Dollar Genera...
AI hype meets real-world finance. This article explains why I remain cautious on CoreWeave stock, with clear risks, n...
Craig Newmark is pledging to donate the bulk of his fortune, about $450 million, to issues such as misinformation and...
In a volatile stretch for investors, Tesla’s AI chip plant plans sparked a rally in the stock market today, march. Th...
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
In a choppy market shaped by inflation and global tensions, three stocks stand out for potential to beat market retur...
Pinterest has shown strong quarterly results, yet the stock moves on mixed signals. This guide breaks down the what's...
SoundHound AI is chasing a $140 billion total addressable market. This article breaks down what that TAM means for in...
As Zebra Technologies previews its Q1 2026 results, investors weigh hardware demand, software subscriptions, and marg...